|
Symbol
|
AHBVTQ | AHFITQ |
|---|---|---|
| Name | Worst of Reverse Convertible | Worst of Reverse Convertible |
|
Basiswert
|
Anglo American / GlaxoSmithKline / Royal Dutch Shell | Anglo American Plc. / AstraZeneca Plc. / Scottish & Southern Energy Plc. |
|
Emittent
|
|
|
|
Fälligkeit
|
14.01.2028 | 04.08.2028 |
| Ratio | - | - |
|
Ausübungs-Preis
|
1'578.00 | 3'078.70 |
|
Maximal- rendite p.a. |
13.81% | 14.92% |
| Geld | 99.78 | 100.08 |
| Brief | 100.58 | 100.88 |